Atloo et al., 2022 - Google Patents
The Bovine Serum Albumin Coated Copper Oxide Nanoparticle for Curcumin Delivery in Biological Environment: In-vitro Drug ReleaseAtloo et al., 2022
View PDF- Document ID
- 16247129177357074917
- Author
- Atloo T
- Mohammadkhani R
- Mohammadi A
- Zaboli K
- Kaboli S
- Rahimi H
- Nosrati H
- Danafar H
- Publication year
- Publication venue
- Journal of Polymers and the Environment
External Links
Snippet
The copper oxide nanoparticles (CuO NPs) were synthesized by a simple method and then coated with the bovine serum albumin (BSA) to form CuO@ BSA NPs. Finally, curcumin (CUR) as an anticancer drug was loaded to the CuO@ BSA NPs. The characterization of …
- QPLDLSVMHZLSFG-UHFFFAOYSA-N copper oxide data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 [Cu]=O 0 title abstract description 180
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
- A61K47/48876—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Guo et al. | Modular assembly of biomaterials using polyphenols as building blocks | |
Qiang et al. | A novel macrophage-mediated biomimetic delivery system with NIR-triggered release for prostate cancer therapy | |
Shen et al. | Fe3O4 nanoparticles in targeted drug/gene delivery systems | |
Wei et al. | Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy | |
Venkatasubbu et al. | Folate targeted PEGylated titanium dioxide nanoparticles as a nanocarrier for targeted paclitaxel drug delivery | |
Ayyanaar et al. | ROS-responsive chitosan coated magnetic iron oxide nanoparticles as potential vehicles for targeted drug delivery in cancer therapy | |
Li et al. | Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy | |
Sabzini et al. | Development of chitosan/halloysite/graphitic‑carbon nitride nanovehicle for targeted delivery of quercetin to enhance its limitation in cancer therapy: An in vitro cytotoxicity against MCF-7 cells | |
Shakil et al. | In vivo toxicity studies of chitosan-coated cobalt ferrite nanocomplex for its application as MRI contrast dye | |
Ruman et al. | Synthesis and characterization of chitosan-based nanodelivery systems to enhance the anticancer effect of sorafenib drug in hepatocellular carcinoma and colorectal adenocarcinoma cells | |
Figueroa et al. | Design and characterization of chitosan-graphene oxide nanocomposites for the delivery of proanthocyanidins | |
Li et al. | Supramolecular assembly of protein-based nanoparticles based on tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) for cancer therapy | |
Rahimi et al. | Needle-shaped amphoteric calix [4] arene as a magnetic nanocarrier for simultaneous delivery of anticancer drugs to the breast cancer cells | |
Bruckmann et al. | Biological applications of silica-based nanoparticles | |
Tarantash et al. | Preparation, characterization and in vitro anticancer activity of paclitaxel conjugated magnetic nanoparticles | |
Lee et al. | Mannosylated poly (acrylic acid)-coated mesoporous silica nanoparticles for anticancer therapy | |
Zarepour et al. | Fabricating β-cyclodextrin based pH-responsive nanotheranostics as a programmable polymeric nanocapsule for simultaneous diagnosis and therapy | |
Ajith et al. | Nanoparticle-based materials in anticancer drug delivery: Current and future prospects | |
Atloo et al. | The Bovine Serum Albumin Coated Copper Oxide Nanoparticle for Curcumin Delivery in Biological Environment: In-vitro Drug Release | |
Pooresmaeil et al. | Metal-organic framework/carboxymethyl starch/graphene quantum dots ternary hybrid as a pH sensitive anticancer drug carrier for co-delivery of curcumin and doxorubicin | |
Bayat et al. | Improving release profile and anticancer activity of 5-fluorouracil for breast cancer therapy using a double drug delivery system: chitosan/agarose/γ-alumina nanocomposite@ double emulsion | |
Nabipour et al. | Sustainable drug delivery systems through green nanotechnology | |
Li et al. | A Review of Cyclodextrin Encapsulation and Intelligent Response for the Release of Curcumin | |
Mi et al. | Preparation of doxorubicin-loaded carboxymethyl-β-cyclodextrin/chitosan nanoparticles with antioxidant, antitumor activities and pH-sensitive release | |
Hemmati et al. | In vitro evaluation of curcumin-loaded chitosan-coated hydroxyapatite nanocarriers as a potential system for effective treatment of cancer |